Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy.

Authors :: Kountouras J
Polyzos SA
Katsinelos P
Zeglinas C
Artemaki F
Tzivras D
Vardaka E
Gavalas E
Romiopoulos I
Simeonidou C
Grigoriadis N
Kountouras C
Dardiotis E
Deretzi G
Source :: International journal of cardiology [Int J Cardiol] 2017 Feb 15; Vol. 229, pp. 17-18. Date of Electronic Publication: 2016 Nov 19.
Publication Year :: 2017

Subjects :: Helicobacter Infections epidemiology
Helicobacter Infections microbiology
Helicobacter pylori drug effects
Helicobacter pylori isolation & purification
Humans
Risk Factors
Anti-Bacterial Agents therapeutic use
Cardiovascular Diseases epidemiology
Cardiovascular Diseases prevention & control
Helicobacter Infections drug therapy
Preventive Medicine methods

Full Text Access

Tools